Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss
Clinical trial NCT02997189 · TERMINATED
Trial details
- NCT number
- NCT02997189
- Sponsor
- Otonomy, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2017-09-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.